Dr. rer. nat. Tanja Müller

Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology Lehrstuhl für Tierphysiologie

Manual cell selection in single cell transcriptomics using scSELpy supports the analysis of immune cell subsets (2023) Dedden M, Wiendl M, Müller T, Neurath M, Zundler S Journal article Etrolizumab-s Does Not Induce Residual Trafficking of Regulatory T Cells (2022) Schweda A, Becker E, Wiendl M, Atreya R, Atreya I, Müller T, Neurath M, Zundler S Journal article Vedolizumab blocks alpha 4 beta 7 integrin-mediated T cell adhesion to MAdCAM-1 in microscopic colitis (2022) Besendorf L, Müller T, Geppert CI, Schneider I, Mühl L, Atreya I, Vitali F, et al. Journal article Limited Dose-Dependent Effects of Vedolizumab on Various Leukocyte Subsets (2022) Becker E, Schweda A, Ullrich K, Voskens C, Atreya R, Müller T, Atreya I, et al. Journal article Expression and function of α4β7 integrin predict the success of vedolizumab treatment in inflammatory bowel disease (2022) Schneider I, Allner C, Mühl L, Melde M, Lissner D, Mantzivi E, Glauben R, et al. Journal article Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study (2021) Mühl L, Becker E, Müller T, Atreya R, Atreya I, Neurath M, Zundler S Journal article α4β7 integrin-dependent adhesion of T cells to MAdCAM-1 is blocked by vedolizumab in patients with chronic refractory pouchitis (2021) Melde M, Müller T, Schneider IHF, Geppert CI, Mühl L, Besendorf L, Allner C, et al. Journal article Residual homing of alpha 4 beta 7-expressing beta 1(+)PI16(+) regulatory T cells with potent suppressive activity correlates with exposure-efficacy of vedolizumab (2021) Becker E, Dedden M, Gall C, Wiendl M, Ekici AB, Schulz-Kuhnt A, Schweda A, et al. Journal article Targeting Immune Cell Trafficking – Insights From Research Models and Implications for Future IBD Therapy (2021) Wiendl M, Becker E, Müller T, Voskens C, Neurath M, Zundler S Journal article, Review article Circulating Adaptive Immune Cells Expressing the Gut Homing Marker α4β7 Integrin Are Decreased in COVID-19 (2021) Müller T, Becker E, Wiendl M, Schulze L, Voskens C, Kremer A, Neurath M, et al. Journal article